Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,361,296
-
Total 13F shares
-
20,651,240
-
Share change
-
-126,461
-
Total reported value
-
$43,573,167
-
Price per share
-
$2.11
-
Number of holders
-
36
-
Value change
-
-$3,308,940
-
Number of buys
-
18
-
Number of sells
-
14
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) as of Q1 2020
As of 31 Mar 2020 Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) had 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,651,240 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Novo Holdings A/S, BVF INC/IL, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, and CHI Advisors LLC.
This table shows 36 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.